en

PRODUCT DETAIL

Kevzara 200 mg injekčný roztok naplnený v injekčnom pere

Code 4672C
MA number EU/1/17/1196/008
Product Form: sol inj 6 (3x2)x1,14 ml/200 mg (pero inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AC Interleukin inhibitors
L04AC14 Sarilumab
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 23.06.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 06.05.2022
eu-flag.png sk-flag.png